Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy. - Gámez-Pozo A; Trilla-Fuertes L; Becerril-Gómez F; Lalanda-Delgado P; Soriano V; Garicano Goldaraz F; Lecumberri MJ; Rodríguez de la Borbolla M; Majem M; Pérez-Ruiz E; González-Cao M; Oramas J; et al. (Cancer immunology, immunotherapy : CII, 2026)